v3.25.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 8,320,713 $ 8,999,496
Marketable securities 25,210,453 29,922,523
Prepaid expenses and other current assets 1,964,327 1,905,360
Deferred offering costs 224,931 0
Grant receivable 2,360,975 2,254,231
Total current assets 38,081,399 43,081,610
Total assets 38,081,399 43,081,610
Current liabilities:    
Accounts payable 1,845,609 1,511,440
Accrued expenses and other current liabilities 2,796,011 2,367,842
Total liabilities 4,641,620 3,879,282
Commitments and Contingencies  
Stockholders’ Equity:    
Common stock, $0.001 par value: 1,000,000,000 shares authorized at June 30, 2025 and December 31, 2024: 9,252,719 and 8,702,719 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 9,252 8,702
Additional paid-in capital 115,315,232 109,868,913
Accumulated other comprehensive (loss) income (783) 56,197
Accumulated deficit (81,883,922) (70,731,484)
Total stockholders' equity 33,439,779 39,202,328
Total liabilities and stockholders' equity 38,081,399 43,081,610
Series A Preferred Stock [Member]    
Stockholders’ Equity:    
Series A preferred stock $0.001 par value: 30,000,000 authorized at June 30, 2025 and December 31, 2024, 0 shares issued and outstanding at June 30, 2025 and December 31, 2024 $ 0 $ 0